IL-1β breaks tolerance through expansion of CD25+ effector T cells

被引:143
作者
O'Sullivan, Brendan J.
Thomas, Helen E.
Pai, Saparna
Santamaria, Pere
Iwakura, Yoichiro
Steptoe, Raymond J.
Kay, Thomas W. H.
Thomas, Ranjeny
机构
[1] Univ Queensland, Princess Alexandra Hosp, Ctr Immunol & Canc Res, Brisbane, Qld 4102, Australia
[2] St Vincents Ctr Med Res, Julia Mcfarlane Diabet Res Ctr, Dept Microbiol & Infect Dis, Melbourne, Vic, Australia
[3] Univ Calgary, Dept Microbiol, Calgary, AB T2N 1N4, Canada
[4] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Tokyo, Japan
关键词
D O I
10.4049/jimmunol.176.12.7278
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-1 is a key proinflammatory driver of several autoimmune diseases including juvenile inflammatory arthritis, diseases with mutations in the NALP/cryopyrin complex and Crohn's disease, and is genetically or clinically associated with many others. IL-1 is a pleiotropic proinflammatory cytokine; however the mechanisms by which increased IL-1 signaling promotes autoreactive T cell activity are not clear. Here we show that autoimmune-prone NOD and IL-1 receptor antagonist-deficient C57BL/6 mice both produce high levels of IL-1, which drives autoreactive effector cell expansion. IL-1 beta drives proliferation and cytokine production by CD4(+)CD25(+)FoxP3(-) effector/memory T cells, attenuates CD4(+)CD25(+)FoxP3(+) regulatory T cell function, and allows escape of CD4(+)CD25(-) autoreactive effectors from suppression. Thus, inflammation or constitutive overexpression of IL-1 beta in a genetically predisposed host can promote autoreactive effector T cell expansion and function, which attenuates the ability of regulatory T cells to maintain tolerance to self.
引用
收藏
页码:7278 / 7287
页数:10
相关论文
共 53 条
[1]   Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes [J].
Achenbach, P ;
Koczwara, K ;
Knopff, A ;
Naserke, H ;
Ziegler, AG ;
Bonifacio, E .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (04) :589-597
[2]   NALP3 forms an IL-lβ-Processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder [J].
Agostini, L ;
Martinon, F ;
Burns, K ;
McDermott, MF ;
Hawkins, PN ;
Tschopp, J .
IMMUNITY, 2004, 20 (03) :319-325
[3]   Diversity of regulatory CD4+ T cells controlling distinct organ-specific autoimmune diseases [J].
Alyanakian, MA ;
You, S ;
Damotte, D ;
Gouarin, C ;
Esling, A ;
Garcia, C ;
Havouis, S ;
Chatenoud, L ;
Bach, JF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (26) :15806-15811
[4]   Checkpoints in the progression of autoimmune disease: Lessons from diabetes models [J].
Andre, I ;
Gonzalez, A ;
Wang, B ;
Katz, J ;
Benoist, C ;
Mathis, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (06) :2260-2263
[5]   Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health [J].
Arif, S ;
Tree, TI ;
Astill, TP ;
Tremble, JM ;
Bishop, AJ ;
Dayan, CM ;
Roep, BO ;
Peakman, M .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (03) :451-463
[6]   TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes [J].
Belghith, M ;
Bluestone, JA ;
Barriot, S ;
Mégret, J ;
Bach, JF ;
Chatenoud, L .
NATURE MEDICINE, 2003, 9 (09) :1202-1208
[7]   Foxp3 interacts with nuclear factor of activated T cells and NF-κB to repress cytokine gene expression and effector functions of T helper cells [J].
Bettelli, E ;
Dastrange, M ;
Oukka, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (14) :5138-5143
[8]   Inferences, questions and possibilities in toll-like receptor signalling [J].
Beutler, B .
NATURE, 2004, 430 (6996) :257-263
[9]  
BRENNAN FM, 1989, LANCET, V2, P244
[10]   X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II [J].
Dessen, A ;
Lawrence, CM ;
Cupo, S ;
Zaller, DM ;
Wiley, DC .
IMMUNITY, 1997, 7 (04) :473-481